Epigral
Epigral Performance
Day Range
- Low 902.05
- High 921.95
52 Week Range
- Low 815.00
- High 1,292.15
- Open Price906.00
- Previous Close905.05
- Volume43554
Start SIP in Epigral
Start SIPEpigral Investment Rating
-
Master Rating:
-
Epigral Ltd has an operating revenue of Rs. 2,033.06 Cr. on a trailing 12-month basis. An annual revenue growth of 41% is outstanding, Pre-tax margin of 24% is great, ROE of 33% is exceptional. The company has a reasonable debt to equity of 41%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. It is currently FORMING a base in its weekly chart and is trading around 23% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 56 which is a POOR score indicating inconsistency in earnings, a RS Rating of 10 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 152 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 478 | 455 | 562 | 538 | 556 | 533 | 499 |
| Operating Expenses Qtr Cr | 370 | 360 | 407 | 371 | 375 | 345 | 324 |
| Operating Profit Qtr Cr | 108 | 95 | 155 | 167 | 180 | 187 | 175 |
| Depreciation Qtr Cr | 32 | 31 | 30 | 31 | 26 | 22 | 21 |
| Interest Qtr Cr | 21 | 18 | 19 | 21 | 14 | 11 | 12 |
| Tax Qtr Cr | 18 | 16 | 33 | 37 | 50 | 49 | 45 |
| Net Profit Qtr Cr | 38 | 32 | 77 | 77 | 92 | 108 | 99 |
Epigral Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹915.72
- 50 Day
- ₹933.58
- 100 Day
- ₹955.79
- 200 Day
- ₹997.33
- 20 Day
- ₹914.07
- 50 Day
- ₹940.18
- 100 Day
- ₹952.18
- 200 Day
- ₹974.47
Epigral Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 918.35 |
| Second Resistance | 930.10 |
| Third Resistance | 938.25 |
| RSI | 43.84 |
| MFI | 62.47 |
| MACD Single Line | -8.84 |
| MACD | -7.14 |
| Support | |
|---|---|
| First Resistance | 898.45 |
| Second Resistance | 890.30 |
| Third Resistance | 878.55 |
Epigral Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 50,452 | 2,976,668 | 59 |
| Week | 37,767 | 1,983,119 | 52.51 |
| 1 Month | 32,278 | 1,646,836 | 51.02 |
| 6 Month | 97,510 | 3,195,408 | 32.77 |
Epigral Result Highlights
Epigral Synopsis
NSE-Chemicals-Specialty
Epigral Ltd is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 2188.40 Cr. and Equity Capital is Rs. 41.55 Cr. for the Year ended 31/03/2023. Meghmani Finechem Ltd. is a Public Limited Listed company incorporated on 11/09/2007 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24100GJ2007PLC051717 and registration number is 051717.| Market Cap | 3,767 |
| Sales | 2,033 |
| Shares in Float | 1.20 |
| No of funds | 58 |
| Yield | 0.55 |
| Book Value | 3.52 |
| U/D Vol ratio | 0.9 |
| LTDebt / Equity | 41 |
| Alpha | -0.15 |
| Beta | 0.98 |
Epigral
| Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
|---|---|---|---|---|
| Promoters | 71.38% | 71.37% | 71.34% | 71.21% |
| Mutual Funds | 0.04% | 0.04% | 0.03% | |
| Foreign Portfolio Investors | 1.14% | 1.16% | 1.2% | 1.15% |
| Individual Investors | 21.05% | 21.22% | 21.13% | 21.43% |
| Others | 6.39% | 6.21% | 6.3% | 6.21% |
Epigral Management
| Name | Designation |
|---|---|
| Mr. Maulik Jayantibhai Patel | Chairman & Managing Director |
| Mr. Kaushal Ashish Soparkar | Executive Director |
| Mr. Ankit Natwarlal Patel | Non Executive Director |
| Mr. Karana Rameshbhai Patel | Non Executive Director |
| Mr. Darshan Anandbhai Patel | Non Executive Director |
| Mr. Manubhai Patel | Independent Director |
| Mr. Sanjay Asher | Independent Director |
| Mr. Kanubhai Shakarabhai Patel | Independent Director |
| Mr. Raju Swamy | Independent Director |
| Ms. Nirali Parikh | Independent Director |
Epigral Forecast
Price Estimates
Epigral Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-11-06 | Quarterly Results | |
| 2023-08-05 | Quarterly Results | |
| 2023-04-25 | Audited Results & Final Dividend | |
| 2023-01-19 | Quarterly Results & Interim Dividend | |
| 2022-10-20 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2023-06-20 | FINAL | Rs.2.50 per share(25%)Final Dividend |
| 2023-02-01 | INTERIM | Rs.2.50 per share(25%)Interim Dividend |
Epigral FAQs
What is Share Price of Epigral ?
Epigral share price is ₹906 As on 02 December, 2023 | 23:34
What is the Market Cap of Epigral ?
The Market Cap of Epigral is ₹3766.9 Cr As on 02 December, 2023 | 23:34
What is the P/E ratio of Epigral ?
The P/E ratio of Epigral is 16.9 As on 02 December, 2023 | 23:34
What is the PB ratio of Epigral ?
The PB ratio of Epigral is 3.5 As on 02 December, 2023 | 23:34